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ABSTRACT 
Selenium (Se) is an essential trace mineral known for its role as an antioxidant in 
oxidation-reduction reactions. Due to deficiency in many parts of the world, development of new 
Se supplementation is increasing in popularity. The objective of this study was to examine the 
bioaccessiblity (BAC) and bioavailability (BA) from Se-rich algae using an in vitro 
digestion/Caco-2 cell model. Algal samples were grown in Se-rich media with varying 
concentrations of either selenite or selenate, then subjected to in vitro digestion. The centrifuged 
supernatent was applied on the Caco-2 cell monolayer for a 24-h treatment. BAC was tested 
based on the Se solubility post in vitro digestion and BA by induction of cellular glutathione 
peroxidase activity (GPx1) in a Se deficient Caco-2 cell model. Algal samples were compared to 
Se-salts, selenomethionine (SeMet) and Se-yeast commonly used in supplementation. Cells 
treated with algae grown in selenate had a mean GPx1 activity that was 15-62% (p<0.05) of the 
GPx1 activity relative to the cells with SeMet treatment. Cells treated with algae grown in 
selenite had a mean GPx1 activity that was 11-34% (p<0.05) of the GPx1 activity from SeMet 
treated cells. Additionally, the Se-yeast treated cells had 134% (p<0.05) GPx1 activity, selenate 
salt treated cells had 214% (p<0.05) GPx1 activity, and selenite salt treated cells had 126% 
(p<0.05) GPx1 activity of the SeMet treated cells. The results indicated that the Se-rich algae 
was not as effective as traditional Se supplementation in increasing GPx1 activity. However, the 
results provided valuable information to improve future Se BA of algae. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
Background 
 
Worldwide, the distribution of selenium (Se) among soil and water varies greatly, 
creating the issue of Se toxicity, and more often, Se deficiency throughout different regions in 
the world. Some of the Se that enters the environment results from various agricultural and 
industry practices, and sediment from seleniferous rocks1. Worldwide, Se deficiency affects 
approximately 1 billion humans2. It can cause an increased risk of infection, cancer, and increase 
the risk of diseases such as cardiomyopathy3. Deficiency in animals can cause white muscle 
disease, decreased immunity, and even death4-6. Selenium is obtained in the diet through a 
variety of plant and animal sources, however, because of the environmental inconsistencies, 
these sources also vary with levels of Se. Recommended dietary intake in the United States for 
adults is 55 µg/day but some people who live in Se-deficient areas of the world consume less 
than 15 µg of Se per day7-9.     
Understanding how Se is absorbed and utilized in the body is complex. There are several 
factors that influence its bioaccessibility (BAC) which is the absorbable fraction of a particular 
compound. Solubility, pH, and the chemical form of Se are just a few examples that result in 
most organic forms to be absorbed better than most inorganic forms of Se10,11. The route of 
metabolism and how the body can utilize Se for selenoprotein synthesis, storage, or excretion 
also varies by chemical form12,13. Selenium is ambiguous because BAC is not always a good 
indicator of bioavailability (BA), which is the absorbed amount of the element that is delivered 
to tissues for use14. For example, some inorganic Se may have a lower BAC than organic Se, but 
have greater BA compared to organic Se10.  
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With the ever-increasing understanding of how Se impacts our health, more efforts are 
being put into creating more consistent daily intakes among humans and animals7. Algae has the 
ability to accumulate larger concentrations of Se and can be grown in mass quantities4,15,16. With 
wastewaters produced from agricultural and industry practices that can contain high 
concentrations of Se, there is opportunity for creating products that can increase daily Se 
consumption. The following research was conducted to determine how Se is absorbed and 
utilized in a cell model. Using Se-rich algae (Chlorella sp.), we examined the BAC fractions of 
the Se with a Se-deficient Caco-2 cell model and cellular glutathione peroxidase (GPx1) activity 
as a marker for BA. 
Objectives 
 
1. Determine the BAC of Se from Se-rich algae and compare it to the common Se 
supplements* using in vitro solubility 
2. Determine the BA of Se from Se-rich algae and compare it to the common supplements* 
by using GPx activity following cellular uptake  
* SeMet, Na2SeO3, Na2SeO4, and Se-yeast (as controls) 
 
Thesis Organization 
 
This thesis is organized into four chapters including a general introduction and 
background, literature review, a manuscript, and an overall conclusion. Both the manuscript in 
chapter 3 and references at the end of each chapter are formatted based on the requirements of 
the Journal of Agricultural and Food Chemistry. 
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CHAPTER 2. LITERATURE REVIEW 
 
Role of Selenium in Human and Animal Health 
 
Selenium has a multitude of important roles in the body making it an essential daily 
nutrient1,2. Its essentiality to health though was only recently discovered as it was once known 
solely as a toxic element. Now, its main role can be thought of as a secondary antioxidant and 
important cofactor to a number of proteins known as selenoproteins3. The most well-known and 
studied are the glutathione peroxidase (GPx) enzymes that scavenge free radicals formed during 
aerobic metabolic reactions, thus preventing oxidative damage4,5. The relationship of Se with 
enzymes extends to many others such as iodothyronine deiodinase enzymes that are important 
for thyroid hormone synthesis and thioredoxin reductases which are important for a number of 
redox reactions4,6. 
Research with Se’s role in human health has recently expanded to look at how it can affect 
various diseases. Several clinical trials with humans receiving daily Se supplementation have 
examined how Se can reduce the incidence of certain cancers (e.g. liver, colon, prostate) and 
may provide protection against toxicity with certain drugs used with cancer treatment7. 
Monomethylated Se (e.g. methylselenicacid and methylselenol) are thought to be effective 
chemical forms of Se for their ability to enhance apoptosis of androgen-dependent and androgen-
independent cancer cells8-10. Regarding cardiovascular health, Se has been shown in some human 
clinical trials to lower total non-HDL cholesterol and increase HDL cholesterol11. In relation to 
Type 2 Diabetes, low levels of Se in the body have been shown to potentially increase risk of 
complications due to higher levels of oxidative stress12,13. Very high levels of Se in the body, on 
the other hand, may be associated with an increase of insulin resistance14. Overall, the 
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knowledge regarding Se’s necessity to health is rapidly expanding with new research and 
development of new dietary supplements3. 
Chemical Forms of Selenium 
 
Selenium exists as organic, inorganic, or as its elemental form. Inorganic forms are abundant 
in the environment and include elemental Se, selenate and selenite15,16. Several organic 
compounds exist as selenoproteins and selenoamino acids. Selenocysteine (SeCys) is identified 
as the 21st proteinogenic amino acid, which is an amino acid that is incorporated into proteins 
during translation. Selenocysteine, selenocystine and selenomethionine (SeMet) are 
predominantly found in plants and animals15,17,18. Organic, methylated compounds exist such as 
methylselenol, dimethylselenide and trimethylselenonium, which are excretory metabolite 
compounds in humans15,19. Seleno-amino acids and methylated Se compounds are found within 
Se-accumulating plants such as the allium (e.g. garlic) and brassica species (e.g. broccoli and 
cabbage)20,21. Brazil nuts are known to contain large amounts of Se and other good sources of Se 
are beef, poultry, milk, and grains19,22.  
Deficiency 
Selenium is well recognized for its essentiality to toxicity within a small range of 
concentrations. In animals, when daily Se levels are below adequate health problems including 
reproductive issues, growth problems, poor immune function, and white muscle disease can 
occur16,23,24. Deficiency of this element in humans was first recognized in the Keshan area of 
China where a cardiomyopathy known as Keshan Disease was termed as a result of very low 
levels of Se in the diet. Kashin-Beck Disease is a type of osteoarthropathy also resulting from Se 
deficiency, causing oxidative damage to bone and cartilage cells25-28. This area of China 
currently averages a daily Se intake of less than 15 µg26,29. In comparison, the United States has a 
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daily average intake of 60-160 µg, Great Britain 34 µg, and Canada 98-224 µg25. During times of 
Se deficiency there is a reduction of selenoproteins synthesized, including the various GPx 
enzymes and iodothyronine enzymes. It is important to note though that the level of reduction 
toward different selenoprotein synthesis varies depending on their metabolic importance30. 
Several effects can happen from reduction of these enzymes including reduced protection against 
free radical cellular damage, reduced immune function, infertility particularly in men, reduced 
thyroid function, and even an increased risk of certain types of cancer25,27,29. 
Toxicity 
Selenium is well recognized for its U-shaped relationship to health and for its ability to 
quickly reach levels of toxicity1. It was first identified for its toxic effect in animals creating the 
terms ‘alkali disease’ and ‘selenosis’. Signs and symptoms of excessive Se exposure in animals 
range from extreme weight loss, tachycardia, and neurological issues, to reproductive issues, 
deformities, and even death16,31,32. Toxic effects are particularly known to occur in aquatic life 
including egg-laying vertebrates16,31. In the United States, the tolerable upper intake level for 
humans is 400 µg/d but in some countries, daily intake far exceeds this26,32,33. In the Enshi region 
of China in 1983, high levels of Se were exposed in the environment from the coal industry, 
causing toxicity amongst many people. Symptoms included skin lesions, increased white blood 
cell count, and neurological problems when exposed to levels above 850 µg/day32. Other signs 
and symptoms of toxicity include garlic odor in the breath, brittle hair and nails, skin rashes, and 
adverse effects on endocrine, nervous and immune systems34-36. 
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Supplementation 
Current Dietary Recommendations 
 
Recommendations for Se intake varies among different countries. For humans and  
animals, the recommendations for daily dietary intake are based on the amount needed to achieve 
adequate GPx activity29. The current recommended dietary allowance for adult men and women 
in the United States is 55 µg/day and deficiency is considered less than 30 µg daily25,29. In the 
United States, recommendations were originally based on those made in China as 40 µg/d for a 
60 kg adult Chinese male. Based on weight differences between the two countries and individual 
variance with weight, the range of 55-70 µg/d was established for adult men and women37. The 
World Health Organization, on the other hand, recommends 70 µg/day for adults in the United 
States33. Based on more evidence of Se intake related to diseases, experts are suggesting that 
there may be benefit to having a higher daily intake, making supplementation ever more 
popular38. Some researchers suggest that current recommendations are insufficient for optimal 
expression of certain selenoproteins and as much as 300 µg/d may be beneficial26,33. Actual 
intake can vary greatly amongst different countries due to differences in diets. 
Current Supplementation 
 In more recent years, Se was identified as essential to human and animal health, resulting 
in the development of Se supplements for humans, and Se supplemented feed for animals39. 
Supplements such as multivitamins and animal feeds often contain inorganic Se as their salts, 
sodium (Na)-selenate and Na-selenite for their low cost and ability to affectively increase 
selenoprotein synthesis19,25,40. Supplements also often contain SeMet because it is of high 
bioavailability (BA) and is considered the best form of Se to increase overall Se body status in 
humans because it can be stored, unlike inorganic Se39. Supplements that only contain Se often 
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have 200 µg of Se per daily dose, which is an amount based on numerous published studies 
demonstrating the benefits of Se decreasing the risk of certain cancers in humans.39,41,42. 
Selenium-Yeasts 
Selenium-enriched yeasts such as Saccharomyces cerevisiae (S. cerevisiae) are common in 
supplement form for their low cost and ability to accumulate large quantities of the element19,43. 
As supplements, their popularity is attributed to high BA and effectiveness to increase 
selenoprotein synthesis which promotes health in humans and animals44. This results from 
organic Se, such as SeMet, being incorporated into body proteins in place of methionine, 
allowing for that Se to be used at later times of need, as well as increasing Se tissue 
concentration45.  
High concentrations of Se among many plants results in toxicity due to excessive inorganic 
Se reacting with thiols and generating reactive oxygen species (ROS), resulting in oxidative 
damage46. However, some plants and organisms such as yeast have the ability to accumulate 
larger quantities of Se because they metabolize inorganic Se to seleno-amino acids, and 
methylated Se such as Se-methylselenocysteine (MeSeCys )19,47,48. For example, S. cerevisiae 
has the ability to accumulate up to 3,000 µg of Se/g44. Other yeasts that are commonly studied 
for this ability are Candida utilis and Yarrowia lipolytica49. For supplements, S. cerevisiae is 
fermented in a Se-rich, sugar-based medium often containing Na-selenite13. Once inorganic Se is 
taken up by the yeast cells, it is metabolized and organically bound. The majority of organically 
bound Se formed is as SeMet41,49. Although it is difficult to determine all forms of Se in yeast 
supplements, many studies have reported that other identified Se compounds include  SeCys and 
methylselenol47. The amount of inorganic Se in Se-enriched yeasts should be very minimal to be 
considered adequate for supplementation purposes44.  
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Selenium and Algae  
 
      Similar to yeasts, many algae species can absorb larger quantities of Se when grown in  
proper conditions and metabolize it to organically bound forms33. Also, like other plants, algae 
absorb Se mostly as selenate or selenite and some algae species have been reported to synthesize 
and utilize selenoproteins33,50,51. Cultivating algae is typically done through means of a Na-
selenite enriched media, allowing for cell uptake during exponential growth phase of the algae, 
although selenate is more bioavailable with many algae species33,52,53. Some of the most common 
algae species examined with Se-enrichment include Chlorella sp. and Spirulina plantesis33,53. 
Traditional methods of growing and harvesting algae involve use of open pond systems and 
enclosed photobioreactors, often followed by chemical treatment to harvest the algae and reach 
the appropriate concentration for the final biomass54.  
The method of growing algae in such a way to become Se-rich is increasing in popularity for 
several reasons. One is that like Se-rich yeasts, Se-rich algae have been shown to have similar 
beneficial effects on health and allow for incorporation of organically bound Se following 
absorption in humans and animals50,52. Several animal studies involving ewes, chickens, and rats 
have shown increased GPx activity and increased Se tissue concentration after consumption of 
Se-rich microalgae. Although in the same studies, the increase in GPx activity was typically not 
better than with consumption of Na-selenite supplemented in the diet, but enhanced oxidative 
stability is seen in the meat of broiler chickens33,53,55. Another reason is that the method of  
cultivating algae in Se rich media provides opportunity for minimizing regions of Se-toxic 
waters that can be the result from agricultural practices, which is a benefit to the environment52.  
 Regardless of Se content, however, certain strains of algae offer a variety of health 
benefits when supplemented in the diet of humans and animals56. Chlorella sp. is popular for its 
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higher protein composition of approximately 50%. Approximately 20% of its composition is 
lipids, including several monounsaturated fatty acids such as oleic acid and palmitoleic acid, and 
many polyunsaturated fatty acids such as linoleic and linolenic acid57-60. Chlorella sp. also 
contains vitamins such as vitamin C and E, and minerals such as iron, zinc, calcium, and 
phosphorus. The composition of Spirulina plantesis is approximately 60% protein and 15% 
lipids. This algae species is rich in several monounsaturated fatty acids as well as linoleic acid, 
linoleic acid, docosahexaenoic acid, and several other polyunsaturated fatty acids56-59. It contains 
vitamins such as vitamin E and B12, as well as several minerals including iron, magnesium, zinc, 
selenium, and calcium56. Both algae species contain fiber, all of the essential amino acids, and 
offer several health benefits from these nutrients61. Utilizing algae species such as these for Se 
enrichment could provide a natural source of Se for humans and animals56. 
Selenium in the Environment 
Soil content of Se varies greatly in the environment and its BA in plants is affected by 
conditions such as soil content, soil pH, and moisture level34. It is mainly present in soils as its 
elemental form or as inorganic Se, including selenate, selenite, and various inorganic salts62. 
Most plants absorb inorganic Se and have the ability to transform it into organic forms63,64. 
Because of the limited ability to absorb much Se, many plants contain less than 25 µg of Se/g of 
dry weight. Some plants are considered Se-accumulating for their ability to transform inorganic 
Se into organic Se for incorporation into non-protein amino acids compared to plants that 
experience adverse effects to incorporating Se into proteins. These plants can accumulate Se at 
up to 1-15 mg of Se/g of dry weight64,65. Some soil can have high levels of Se but the BAC in 
plants is low because of these varying conditions such as pH and moisture level. Therefore, Se 
content in soil, typically as selenite, selenate, or elemental Se accounts for many differences of 
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Se levels in plants and animals, which therefore, affects dietary intake in humans and 
animals26,66. 
There are several causes to the differences of environmental Se, often due to coal and 
phosphate mining, and agricultural irrigation practices16,49.  Much of the naturally occurring Se 
originates from rock erosion63. Because of the uneven distribution of Se in soil and water 
throughout the world, there are areas of toxic levels of Se, often caused by runoff produced from 
industry and agricultural water systems23. There are even more areas with very low Se in soil, 
creating several challenges revolving around Se deficiencies46,68,69. 
Selenium’s Role in the Animal Feed Industry 
 
Within the animal feed industry, there is the constant challenge of providing livestock with 
adequate daily amounts of Se. Livestock that rely heavily on foraging are at risk of deficiency if 
those plants contain low levels of Se34. Many feeds do not contain enough Se to meet the range 
of 0.1-0.3 mg/kg, which is considered adequate for animal health69. Se levels in some livestock 
feed can be as low as 0.03-0.12 mg/kg of dry matter, therefore, supplementation is necessary. 
Adding Se can bring its concentration to recommended levels of 0.3-0.5 mg/kg of dry matter24. 
Currently, the Food and Drug Administration has regulations set at Se added to feed as either 
Na-selenite, Na-selenate, SeMet, or Se-yeast from S. cerevisiae to not exceed 0.3 ppm70. 
The majority of feeds that are supplemented with Se use inorganic Se-salts (Na-selenite, Na-
selenate, calcium-selenite) because of their lower costs and effectiveness in improving animal 
health22,33. Organic compounds such as Se-yeasts are becoming more popular33,69. The 
predominant form of Se in yeasts is SeMet and a benefit of using organic compounds is that it 
can be stored in the body proteins as well as be utilized for selenoprotein synthesis. 
Supplementation is used to ensure animals are receiving appropriate amounts of daily Se to avoid 
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deficiency. Daily supplementation ensures proper growth, reproduction, and high performance in 
the animals22,24. 
A study conducted at California State University evaluated the effects that Se-rich canola oil 
seed cake meal would have on the Se milk and blood levels in cattle compared to canola oil not 
fortified with Se. This method had the benefit of removing excess Se from the environment by 
utilizing canola, which has the ability to uptake larger amounts of Se. It also increased Se milk 
concentrations in the cattle compared to the control, and maintained adequate Se blood levels69.  
Absorption 
 
Bioavailability vs Bioaccassibility 
 
Because of the complexity of Se metabolism, it is important to distinguish between 
bioaccessibility (BAC) and BA. Soluble fraction of a compound following gastrointestinal 
uptake is termed BAC, which is dependent on factors such as pH and type of food matrix71,72. 
BA refers to the absorbed portion that becomes available to cells for use25. Selenium BAC and 
absorption, therefore, is dependent upon the chemical form consumed40. Other terms often used 
regarding Se absorption and metabolism include non-bioaccessible, which refers to the 
unabsorbed portion of a compound, and bioactivity, which refers to the portion of a compound 
that becomes metabolically active (Figure 2.1) 71. 
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Figure 2.1 Terminology used to describe Se once ingested. (1) Non-bioaccessible refers to Se unabsorbed that 
is excreted in feces; (2) Bioaccessible refers to Se that is absorbed across intestinal epithelia; (3) Se that reaches 
systemic circulation and is available for cells to use represents the bioavailable portion; (4) Bioactive Se 
represents the fraction made into metabolic compounds and utilized71. 
 
Routes of Absorption 
 
 Selenium absorption appears to be unregulated73. Most chemical forms of Se are well 
absorbed within ranges of 60-98%, with the exception of elemental Se being much lower. 
Selenite absorption is typically around 60% and Selenate around 95%. Selenomethionine is 
known to be better absorbed with absorption of 95-98%.  Methylated versions of Se and SeCys 
are similar to SeMet40,74,75. Some Caco-2 cell uptake studies though have reported Se-
methylselenocysteine (MeSeCys) to be better absorbed than SeMet76. 
The subject of Se BA is complex. Although most forms of Se are well absorbed, their BA 
can be very different from each other. Methylated Se such as MeSeCys is not as effective as 
increasing Se in body proteins as SeMet but has been shown to induce a higher GPx activity71,77. 
Organic Se species such as SeMet and Se-yeasts have similar responses to GPx activity and are 
both able to be stored in the body. Inorganic selenate and selenite, however, cannot be stored in 
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the body and are immediately reduced for selenoprotein synthesis or excretion. Although selenite 
is not absorbed as well as organic forms, it tends to induce a greater GPx activity and reaches a 
quicker plateau of Se concentration in blood than organic Se71. Inorganic Se is considered more 
toxic because of the pathway it follows and for its ability to become a prooxidant due to its 
reactions with thiols when in excess76,78.  In ruminant animals, it has been reported that Se BAC 
is lower because the microbial environment reduces much of the Se to the poorly absorbed 
elemental Se79. 
Absorption of Se occurs throughout the small intestine, and generally increases further down 
in the small intestine80. Much of Se absorption is related to amino acid absorption75. Multiple 
active transporters are utilized for amino acid absorption. One is the Na+ dependent Bo active 
transporter for neutral amino acids81. Expression of this transporter increases further down the 
small intestine and has varying affinity for neutral amino acids, with higher affinity for 
methionine compared to cysteine. Other Na+ dependent amino acid transports transporters 
assisting with SeMet uptake include the bo,+rBAT and SIT1 transporters. Each of these 
transporters are expressed in varying degrees in the intestines and kidneys82.   
Another amino acid transporter with higher expression in the jejunum compared to other 
portions of the small intestine is the ASCT2 transporter. This transporter is Na+ dependent and 
transports several amino acids across the epithelial, including methionine83. Because of this, 
SeMet is rapidly absorbed and to a greater extent compared to inorganic Se in all sections of the 
small intestine. The greatest absorption for SeMet takes place in the jejunum, and lesser amounts 
in the duodenum and ileum. Selenocysteine has also been shown to mainly utilize passive 
diffusion but can also the bo,+rBAT transporter82,84. Due to its molecular size, selenite goes by 
means of paracellular transport and passive diffusion while selenate can utilize paracellular 
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transport and Na+ dependent transporters85. Both inorganic species increase their absorption 
further down the small intestine, with the greatest percentage occurring in the ileum86.   
Absorption Enhancers and Inhibitors  
 
Several factors can influence Se status in humans including food composition, age, current 
health status, and pharmaceutical drug usage1. In several studies analyzing effects of Se BAC 
and BA in seafood, seaweed, and mollusks, fat emulsification did not affect Se absorption. 
Carbohydrate content including soluble fiber overall does not affect Se absorption and solubility. 
How protein affects Se BAC is somewhat conflicting. In the studies involving seafood, the 
amino acids present in the in vitro digest increased ionic strength and lowered Se solubility87. 
Other studies have suggested that protein can improve Se absorption. Vitamins A and E have 
been reported to improve Se absorption. Ascorbic acid has been reported to both enhance and 
inhibit the absorption of Se, depending on the chemical form of Se consumed47,88,89. Ascorbic 
acid may reduce some forms of Se such as selenite to its elemental form, greatly reducing its 
BAC. The presence of heavy metals, particularly cadmium, zinc, and mercury can greatly limit 
absorption of Se22,90. Differing pH in the small intestine may affect the level of absorption. In the 
duodenum pH is between 5 and 6, while in the jejunum and ileum it is around 7. Most Se is 
better absorbed further down the small intestine where the pH is higher89. During intestinal 
epithelial cell uptake, organic Se  and selenate compete for absorption with its sulfur analogues 
while selenite is not affected79,91.  
Metabolism 
 
Relationship with Sulfur 
 
The analogous relationship between Se and sulfur allows for the versatility of Se in plant 
and animal metabolism92. Similarities between Se and sulfur allow for Se to enter metabolic 
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pathways in place of sulfur, such as the trans-selenation pathway and to be incorporated non-
specifically into proteins in place of methionine and 
cysteine (Figure 2.2). In many cases, selenols have 
metabolic advantage over sulfur containing thiols. 
Compared to thiols, selenols are more acidic, more 
nucleophilic, and more easily oxidized93,94. These 
variations make Se compounds more favorable and 
reactive95.  
Metabolic Pathways 
 
Once absorbed, Se follows three main regulated 
routes of metabolism: selenoprotein  
synthesis, incorporation into proteins as SeMet and methylation for excretion96-98. Immediately 
following intestinal absorption, selenite is rapidly and selectively taken up by red blood cells. 
Through a spontaneous reaction with glutathione (GSH), selenite is reduced to 
selenodiglutathione62,99. This compound is then reduced to glutathioselenol by GSH where it can 
then be converted to elemental Se and GSH or reduced by GSH to hydrogen selenide (H2Se). 
Selenite can also be reduced to H2Se by thioredoxin and the thioredoxin reductase enzyme100. 
The H2Se is transported by albumin to the liver via the hepatic portal vein for further processing 
into selenoproteins62,91.  
Little is currently known about how selenate is immediately reduced to selenite. It has been 
suggested that a membrane bound selenate reductase may be used in a manner similar to some 
microorganisms68. Another proposed method for selenate reduction involves ATP sulfurylase 
which converts selenate to adenosine selenophosphate before reducing it to selenite101. Once 
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selenite and selenate are reduced to H2Se, selenoprotein synthesis can occur102. Excess Se can be 
methylated and excreted in the form of urinary metabolites103. One reaction involves converting 
H2Se to methyl selenide by methyl transferase, and then additional methylated Se compounds are 
formed104. These metabolites include methylselenol, which is the active methylated form of Se 
for biological use and selenosugar B, which can be oxidized to methylselenic acid that can be 
available to the body during Se deficiency. 
Other urinary metabolites include 1b-
methylseleno-N-acetyl-D-galactosamine, 
dimethyldiselenonium, and 
trimethylselenonium97,105. Dimethylselenide is 
an additional metabolite that can be excreted 
through the breath100. Organic Se is also 
transported by albumin to the liver for 
metabolism106. Because Se is analogous to 
sulfur, they share similar routes of 
metabolism. Selenomethionine can be inserted 
into body proteins rather than methionine, allowing for storage and availability to amino acid 
pools107,108. It can also be converted to methylselenol, which can be further processed for 
excretion or demethylated to H2Se for further processing109. Similar to the trans-sulfuration 
pathway, SeMet  can enter the trans-selenation pathway to synthesize H2Se, making Se available 
for selenoprotein synthesis (Figure 2.3)28. The initial step of the trans-selenation pathway 
involves SeMet reducing to Se-adenosylmethionine (SAM) by the enzyme SAM synthetase and 
to then Se-adenosylhomocysteine (SAH) by methyl transferase. From there, the compound is 
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hydrolyzed to Se-homocysteine by SAH hydrolase and by cystathionine b-lyase, is converted to 
Se-cystathionine. Cystathionine g-lyase then converts Se-cystathionine to SeCys which is then 
reduced to H2Se by selenocysteine b-lyase106,110,111. Both methylselenocysteine and SeMet can 
be converted to methylselenol by g-lyase and b-lyase, respectively with the intermediate 
compound being methylselenic acid105,111.  
Selenoproteins 
 
Selenoproteins are proteins synthesized in the body, all requiring at least one SeCys in their 
active centers to function. At least 25 selenoproteins have been identified35. They have a variety 
of important roles in the body including thyroid hormone synthesis, free radical scavenging, 
immune health, reproductive health and fertility, involvement in redox reactions, and even 
reduce virulence of some infections112,113. Among the most well-known and investigated are the 
GPx enzymes, the majority of which prevent oxidative damage during aerobic metabolic  
reactions114. Selenoprotein P (Sepp) is a major selenoprotein and member of the thioredoxin 
family115. It carries up to 10 selenocysteines and transports Se from the liver to other tissues. It 
also acts as an antioxidant, reducing phospholipid hydroperoxides and preventing oxidation of 
low-density lipoproteins and peroxinitrite-mediated oxidation116. It represents the largest portion 
of Se in human serum and serves as an indicator of Se nutritional status in humans115,117. 
Deiodinase enzymes 1 and 2 convert the thyroid hormone thyroxine to the active 
triiodothyronine and the other serves to deactivate triiodothyronine118,119. Thioredoxin reductase 
is an important enzyme for redox reactions such as those that maintain the redox state of 
transcription factors120,121. Selenophosphate synthetase is essential for the production of 
selenoproteins by producing selenophosphate from H2Se122. Selenoprotein W acts as an 
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antioxidant but its role as such is not yet well understood. Selenoprotein T, selenoprotein O, and 
selenoprotein N also have functions not yet well understood123,124. 
Selenoprotein Synthesis 
 
Selenoprotein synthesis begins with the central compound to Se metabolism, H2Se. When 
metabolic demands require selenoproteins, both organic and inorganic Se are transformed into 
H2Se125. The H2Se compound is first phosphorylated to selenophosphate by selenophosphate 
synthase 2. Selenoprotein synthesis is a unique process that utilizes selenophosphate as a 
substrate and co-translational incorporation of SeCys by the UGA codon100. Traditionally, UGA 
functions as a stop codon but specific secondary mRNA stem loop structures known as mRNA 
inserting sequences recognize UGA and recode it to allow for its function as a SeCys 
codon107,125,126. Selenocysteine inserting sequence binding proteins recognize this sequence, 
initiating binding of tRNA[ser]sec. Seryl-tRNA synthetase converts tRNA[ser]sec to Ser-tRNA[ser]sec. 
Next, phosphorylation by phosphoseryl-tRNA kinase generates P-Ser-tRNA[ser]sec. 
Selenocysteine synthase uses the selenophosphate as a Se donor, to make P-Ser-tRNA[ser]sec. The 
last step utilizes the UGA codon to incorporate SeCys into the polypeptide chain for 
selenoprotein synthesis95,110,127. 
Homeostasis 
 
Homeostasis of Se is regulated primarily by the liver and achieved through storage in body 
proteins and excretion through the kidney and respiratory system73,106,128. In total, the average 
human body contains 10-20 mg of Se, with about half of the Se located in the skeletal muscle. 
Within plasma, Sepp accounts for approximately 53% of total plasma Se and plasma glutathione 
peroxidase (GPx3) accounts for approximately 39% of plasma Se. Albumin, which transports Se 
to the liver after absorption accounts for approximately 9% of total plasma Se116. Highest tissue 
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concentrations of Se are seen in the liver, kidneys, testes, and hemoglobin34. Selenomethionine 
can be incorporated into proteins and tissues in place of methionine and to a greater extent in 
tissues such as skeletal muscle, red blood cells, and the kidneys (Figure 2.4) 129.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Homeostasis of selenium is achieved through storage in body proteins, generation of selenoproteins, and 
excretion113 
 
In times of surplus Se, generation of multi-methylated urinary metabolites and renal 
excretion is the main route of elimination130. In times of Se deficiency, the body tightly regulates 
and reduces the production of selenoproteins in order of their metabolic importance. Excretion 
through urine still occurs but mainly with monomethylated Se and through the breath by 
dimethylselenide128. Glutathione peroxidase enzymes drastically decrease in synthesis as well as 
many other selenoproteins, while type 1 iodothyronine deiodinase is initially affected to a lesser 
degree124,131,132. Selenocysteine b-lyase may be involved with regulating increased Se uptake to 
the brain111. Because Sepp helps to maintain selenoprotein status in the brain and testis, its 
synthesis and plasma concentrations decrease less than other selenoproteins during Se 
deficiency115,133. Selenoprotein P in fact, has been considered to be a marker of Se status in 
humans because it carries the majority of plasma Se131,134. In several mice studies, during Se 
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deficiency and or deletion of Sepp, Se concentration in tissues decreases to a greater extent in 
tissues such as the liver and testis, but less in tissues such as the brain, heart, and kidney28. 
During repletion of Se in the diet, inorganic and organic Se are effective at restoring enzyme 
activity135. 
Glutathione Peroxidase and Oxidative Damage 
 
Oxidative stress can occur as a result of normal metabolic processes but can also result from 
environmental stressors such as cigarette smoking. Oxidative stress is a contributor to diseases 
such as cardiovascular disease, diabetes, cancer and is also a contributor to aging136-138. Redox 
reactions generate ROS such as superoxide (O2-) and hydrogen peroxide (H2O2), which are 
damaging to cell membranes and protein function if they are not properly eliminated or are 
present in excessive amounts139,140. One way that H2O2 can damage a cell is by reacting with 
metals nearby, producing a hydroxy radical.  The hydroxy radical can cause cell membrane lipid 
peroxidation and production of toxic byproducts that inactivate important cellular enzymes141. 
Reactive oxygen species do have vital roles though such as secondary messengers in cellular 
transduction  reactions142. During inflammatory immune response, superoxide dismutase can turn 
O2- to H2O2 in response to invading pathogens, but if left available for too long, can cause tissue 
damage140.The GPx family consists of enzymes that act as antioxidants, catalyzing the reduction 
of hydrogen peroxides using two reduced glutathione molecules (GSH) to two water molecules 
and oxidized glutathione (GSSG)143. They also reduce lipid peroxides to lipid alcohols140,144. 
Oxidized glutathione and NADPH + H+ then go through a reaction catalyzed by glutathione 
reductase to reduce GSSG, resulting in the reduced glutathione, GSH, and NADP+143,145.  Figure 
2.5 displays the mechanism of oxidative damage and how GPx interferes. 
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Figure 2.5 Mechanism of oxidative damage caused by ROS. GPx functions to reduce ROS in the form of hydrogen 
peroxide to water and oxygen. Glutathione reductase follows by reducing cellular GPx146. 
 
Currently eight GPx enzymes have been identified, most of which require a SeCys at the 
catalytic sites of the homotetramer compound147. Cellular glutathione peroxidase is present      
throughout the body and its activity is utilized for many studies regarding Se BA. 
Gastrointestinal GPx is mainly present in the gastrointestinal tract and liver. Plasma glutathione 
peroxidase, as previously described, is present in the plasma but also several organs143,148. 
Phospholipid GPx is present at high concentrations in the testis, but  also located throughout the 
body as it protects specifically against phospholipid peroxidation142. Glutathione peroxidase 5 is 
seen in sperm nuclei, embryo tissue, and olfactory epithelium. Glutathione peroxidase 6 has been 
identified, but its function is currently unknown148. Glutathione peroxidase 7 and 8 are both 
thought to act as antioxidants but also are involved with protein folding in the endoplasmic 
reticulum of cells62. 
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Methods of Selenium Bioavailability Assessment 
Several methods exist for determining Se BA. For any mineral to be absorbed it has to be in 
soluble form. Cell models, particularly using Caco-2 cells are used commonly as they can easily 
be used to examine the absorbable fraction of Se. Caco-2 cells are favorable because they are a 
colon adenocarcinoma cell line that create a cell monolayer representative of the intestinal 
lining149,150. Many mammalian cells require serum to contain 30-50 nmol/L of Se to maintain 
their growth. Because serum containing medias can contain trace amounts of Se, studies using 
these cells often follow a gradual serum reduction method to make the cells Se deficient18,77. 
Following in vitro digestion Se compounds can be directly added to the cell monolayer which 
allows for a more accurate representation of how the compound would be digested in humans 
and animals34. Following cell uptake of a Se treatment, Se content and enzyme activity in the 
extract can easily be tested151. Many animal models are utilized to examine the Se concentration 
in blood and organs and enzyme activity, particularly follow restoration of Se-depletion in the 
diet71,135. Level of Se excreted through urine, breath, and feces can also easily be tested. A 
multitude of studies in rats, mice, chickens, ewes, and cows have been conducted to aid in the 
understanding Se BA152-155. In humans and animals, Se-blood concentration and serum GPx 
activity can be used to determine BA153. For long-term Se status in humans, Se concentration in 
toenails and  hair has shown to be an effective method of assessment. Urine concentrations can 
be measured to determine the level of excretion of various Se compounds152,153.  
Conclusion 
 
This literature review detailed the necessity of Se in the diets of humans and animals, as well 
as its importance and consequences of Se deficiency/toxicity. It also explained the absorption 
and metabolism of different chemical forms of Se, which is important to understand when 
studying the effects this element has in the body. With inadequate daily intake comes many 
25 
health problems including oxidative damage that can lead to chronic disease and increase risk for 
certain types of cancer. Other notable health problems include thyroid hormone dysfunction, 
reproductive, and nervous system issues. Toxicity of Se can be equally damaging to health. Se 
concentration in soil and water greatly varies around the world for a number of reasons, creating 
inconsistent and often low dietary intake. This creates opportunity for development of new Se 
supplementation. Algae can remove Se from wastewaters and at the same time, use it for animal 
feed. It is therefore important to study BA from this novel Se-rich algae. More methods are  
developing utilizing algae for its ability to grow well while taking in high concentrations of 
inorganic Se. The following research was designed to find the potential that Se-rich algae has for 
future animal supplementation. 
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Abstract: New methods for selenium (Se) supplementation are emerging. The objective of this 
study was to test the Se bioaccessibility (BAC) and bioavailability (BA) of Se-rich algae. Algal 
samples were cultivated in media containing selenite or selenate then compared to Se-salts, Se-
yeasts and Se-amino acids from traditional supplementation. BAC was tested based on the Se 
solubility post in vitro digestion and BA by induction of cellular glutathione peroxidase activity 
(GPx) in a Se deficient Caco-2 cell model. Cells treated with algae grown in selenate had a mean 
GPx activity that was 15-62% (p<0.05) of the GPx activity relative to the cells with SeMet 
treatment. Cells treated with algae grown in selenite had a mean GPx activity that was 11-34% 
(p<0.05) of the GPx activity from SeMet treated cells. Se-rich algae did not increase GPx 
activity as well as traditional supplementation forms, but the results give insight for improving 
Se BA studies. 
Keywords: selenium, algae, glutathione peroxidase, Caco-2 cell model  
Introduction 
Selenium (Se) is an essential mineral to human and animal health. It is known for its 
antioxidant and inflammatory properties, maintaining thyroid hormone metabolism, and even 
39 
protective properties against certain forms of cancer18,107,108. One of its most studied roles is as a 
cofactor of cellular glutathione peroxidase (GPx). As all selenoproteins, GPx requires a 
selenocysteine (SeCys) at its catalytic cite and is essential for removal of reactive oxygen species 
generated from aerobic metabolic reactions96,109. Specifically, GPx catalyzes the reaction of a 
hydrogen peroxide and two reduced forms of glutathione molecules, resulting in an oxidized 
glutathione and water80,89. Depending on the dose and which chemical form Se is consumed 
though has an influence on the level of GPx activity.89  
When assessing Se metabolism, it is important to distinguish bioaccessibility (BAC) from 
bioavailability (BA), and how the body metabolizes the different chemical forms of this element. 
Absorbable fraction such as solubility of an element during gastrointestinal digestion is referred 
to as BAC. Once absorbed, an element can be distributed to cells for use, characterizing its 
BA15,110,111. Selenomethionine (SeMet) is often considered to have the greatest BAC and is less 
toxic compared to inorganic Se24. Inorganic selenite is typically shown to have lower BAC than 
the organic forms and cannot be stored in the body but inorganic selenate tends to have a BAC 
comparable to organic Se15. However, selenite has been shown to induce a higher cellular GPx 
activity compared to organic Se because it is immediately reduced to an available form for 
selenoprotein synthesis45,77. Other studies suggest that organic selenized yeast has higher BAC 
than inorganic Se but also results in a lower GPx activity112. Overall, once Se is absorbed, it 
follows three main routes of metabolism: selenoprotein synthesis, incorporation into body 
proteins, or excretion.18,43 
The mechanism of Se absorption is dependent upon the chemical form consumed. SeMet 
is absorbed to a greater extent throughout the small intestine compared to inorganic forms, 
particularly in the jejunum using active transporters along with its sulfur analogues27,28. Selenate 
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is absorbed via Na+-dependent active transporters and increases further down the small 
intestine113. Selenite on the other hand, utilizes passive diffusion which also increases further 
down the small intestine26,29,32. Following intestinal epithelial uptake, inorganic Se is selectively 
taken up by the red blood cells and immediately reduced to hydrogen selenide (H2Se) and 
transported by albumin to the liver for selenoprotein synthesis or Se excretion6,45. SeMet follows 
a longer trans-selenation pathway to generate H2Se, which is similar to the trans-sulfuration 
pathway taken by methionine.43,80 H2Se is then converted back to SeCys for co-translational 
incorporation into various selenoproteins by the UGA codon, or methylated for excretion.18,43,80  
In supplementation, inorganic Se-salts and Se-rich yeasts are commonly used2,17. Algae 
though is being recognized more for its economic advantage and ability to hold high 
concentrations of Se114. Incorporating Chlorella sp. into dietary supplements is popular because it 
is a natural product containing a variety of vitamins (i.e. vitamin C and E), minerals (i.e iron and 
calcium), and fiber26,27. Over 50% of Chlorella sp. dry mass is as protein, providing all of the 
essential amino acids. Approximately 26% of the dry mass is lipids, providing several 
polyunsaturated and monounsaturated fatty acids such as oleic acid and linoleic acid28-30.  
 Gross-Wen Technologies, LLC (GWT) has developed a Revolving Algal Biofilm 
System (RAB) that produces quantities of algal biomass that are 10 times greater compared to 
other existing systems such as open-pond systems. The RAB system is cost effective and has the 
ability to remove nutrients like Se from the effluent generated in food manufacturing31. 
However, no studies are reported to date on the BA of Se from the algal biomass. Current 
methods for Se BA and BAC include animal and cell models. BAC can be measured with 
solubility after in vitro digestion as a surrogate. GPx activity is often used as a surrogate to Se 
BA in a cell model because it gives an accurate representation of the intestinal uptake of different 
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forms of Se32,33. The objectives of this study were to assess the BAC and BA of Se from the 
algae grown in different conditions with varying concentrations of selenite and selenate, and 
compare them to organic and inorganic Se often used in supplements. 
Materials and Methods 
Materials 
L-Selenomethionine (SeMet), pancreatin and pepsin were purchased from Millipore 
Sigma (MA, USA); Sodium Selenite (Na2SeO3) from Alfa Aesar (MA, USA), and Sodium 
Selenate (Na2SeO4) were obtained from Fisher Scientific (MA, USA). Natural Factors 
SelenoExcell Selenium Yeast (Yeast) was from Natural Factors (USA). For the cell culture, a 
human adenoma carcinoma cell line (Caco-2) was obtained from American Type Culture 
Collection (USA). For the media, fetal bovine serum (FBS) was purchased from Atlanta 
Biological (GA, USA); Advanced Dulbecco’s Modified Eagle Medium (DMEM), Gibco HEPES 
1M, Gibco Antibiotic-Antimycotic 100x solution, and Gibco L-Glutamine 200 mM from Life 
Technologies, Thermo Fisher Scientific (CA, USA). Glutathione Peroxidase Assay Kits were 
purchased from Cayman Chemicals, (MI, USA). Phosphate Buffered Saline (PBS) and 0.5% 
Trypsin EDTA were purchased from Life Technologies, Thermo Fisher Scientific (CA, USA). 
Preparation of Algal Samples 
Se-rich algal samples were cultivated and harvested in the GWT lab at Iowa State 
University, Ames, IA. One-liter medium reservoirs were used to grow Chlorella sp. in a bold 
basal medium. Each reservoir had 0.12 m2 of attached material that revolved in and out of the 
reservoirs and contained a different concentration of either selenate or selenite (10, 30, 50, 100, 
or 200 ppm). Specified levels of sulfite were also added to the medium (0 or 200 ppm). As a 
control to the RAB, a conventional bubble column reactor was also used to cultivate algae. Algae 
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was harvested at varying time frames of either week 1, 2, 3, 4, or 5 of growth and Se content in 
dry mass was measured post-harvest by inductively coupled plasma optical emission 
spectroscopy analysis (ICP-OES).  
In Vitro Simulated Human Digestion 
SeMet, Na2SeO3, Na2SeO4, Yeast, and Se-enriched algal biomass provided by GWT 
containing 200 µg Se were subjected to simulated in vitro human digestion for assessing soluble 
Se, as well as Se uptake in the cell culture model for assessing BAC and BA, respectively. Each 
sample with 200 µg of Se was mixed with Mili-Q water to create a slurry. The slurry was 
initially adjusted to pH 2 and incubated along with pepsin at 37°C for 1 hour while shaking at 
300 rpm to simulate gastric digestion. After adjusting to pH 6 and adding pancreatin, the samples 
were incubated again at 37°C for 1 hour while shaking at 300 rpm to simulate duodenal 
digestion. Enzyme deactivation was achieved by boiling the samples for 4 minutes immediately 
following second incubation as suggested for iron34. Finally, samples were centrifuged at 1070 x 
g for 15 minutes at 37°C before collecting supernatant and storage at -20°C. Se content was 
measured in duplicates using ICP-OES system to assess percent solubility and intestinal cellular 
uptake of Se. Although approximately 70 algal samples in total went through in vitro digestion 
and solubility analysis, only a selected number were used for cell treatments. Selection was 
based on samples that had approximately 10% solubility and above. Table I lists the algal 
samples that were used for the remainder of the study, including a description of the names and 
designated letter. 
Cell Culture 
Caco-2 cells were grown at 37°C with 5% CO2 and DMEM containing 10% FBS. The 
cells were maintained by weekly passage by washing with PBS and then with 0.5% Trypsin 
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EDTA to disassociate the cells after reaching 90% confluency. For the cell uptake experiments, 
cells were passed to 6-well plates in DMEM with 10% FBS at a cell count of 190,000 cells/mm3 
per plate well. Because serum used in the culture media contains trace levels of Se, the cells were 
made Se deficient to assure optimal uptake of Se. This was achieved by growing them with 
DMEM supplemented with 10% FBS for 2 days, followed by 5% FBS for 2 days, and then 0% 
FBS for 6 days. At the end of 6 days, the cell model became Se deficient as measured by GPx 
activity (Figure 3.1). We used these Se deficient cells for Se uptake experiments.  
For BA experiments, immediately after the serum reduction period, the cells were washed 
with PBS. They were then treated with 4mL of serum free DMEM and 1mL of in vitro digest 
supernatants containing 100 nmol/L of Se either from SeMet, Na2SeO3,  Na2SeO4, Yeast, or Se-
enriched algal biomass, with duplicates of each treatment. Treatment remained on the cells for 24 
h to induce GPx activity prior to harvesting with 1mL of cold buffer (50mM Tris-HCl, pH 7.5, 
5mM ethylenediamine tetraacetic acid, and 1mM dithiothreitol) and then sonicated for 4 seconds 
on ice. The samples were stored at -80°C prior to being thawed and centrifuged at 10,000 x g for 
15 minutes at 4°C for protein analysis using the PierceTM Coomassie Bradford Protein Assay Kit 
(Thermo Fisher Scientific CA, USA) and GPx analysis. Two uptake measurements were made 
from each duplicate digestion. 
Statistical analysis 
The GPx activity between Se deficient and Se sufficient cells was determined using 
Student t-test. Data of BAC (solubility) and BA (Gpx) are shown as mean ± SD and the 
differences among groups were determined by ANOVA with Tukey multiple comparison test for 
BAC and BA.  Duplicate wells of each treatment were used in the cell model as well as 
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duplicates for solubility and GPx testing. Differences among the treatments were considered 
significant at P<0.05 among.  
Results and Discussion 
 
Bioaccessibility 
BAC is determined by solubility of the in vitro digestion. The solubility (%) of the Se-
containing samples was calculated based on the fraction of soluble Se concentrations after in 
vitro digestion from 200 µg of Se. Figure 3.2A compares the solubility of the algae samples 
grown in various concentrations of selenite to SeMet, Na2SeO3, and the Yeast supplement as 
controls. No significant differences were seen in mean solubility between SeMet, Na2SeO3, and 
Yeast (p>0.05) with 84.3%, 74.3%, and 81.6% solubility, respectively. The lower solubility from 
Se-rich algae samples was significantly lower (p<0.05) compared to SeMet, Na2SeO3, and Yeast. 
The algae sample A1 had the highest mean solubility of 30.7%, which was significantly different 
from the other four algae samples (p<0.05). Its growth conditions consisted of 30 ppm selenite in 
media, 0 ppm sulfite, and harvested at week 1 of growth with 0.51% Se in its dry mass. Its 
solubility was also approximately 36% of SeMet. Compared to the other samples with 30 ppm 
selenite and 0 ppm sulfite, the growth conditions for A1 had a shorter cultivation time. Based on 
several previous studies, SeMet is recognized to be more soluble and therefore, have greater 
BAC compared to most other forms of Se, particularly selenite and elemental Se1,32. It is also 
recognized as the best form of Se to raise overall Se status in the body, as it is able to be stored, 
methylated, and can increase selenoprotein synthesis. Selenate, although inorganic, is 
comparable in BAC to organic Se, based on several published studies15,18,32. Selenite has lower 
BAC compared to organic forms of Se such as SeMet, SeCys, and methylselenocysteine35,36.  
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Figure 3.2B compares the solubility of the algae samples grown in various concentrations 
of selenate to SeMet, Na2SeO4, and the Yeast supplement. Again, SeMet, Na2SeO4, and the 
Yeast were not significantly different (p>0.05) with 84.3%, 87.1%, and 81.6% solubility, 
respectively. The Se-rich algae samples all had a much lower solubility and were significantly 
different compared to SeMet, Na2SeO4, and Yeast (p<0.05). Sample A8 had growth conditions 
of 200 ppm selenate in media, 0 ppm sulfite, and harvested at week 2 of growth with 0.31% Se in 
its dry mass. It had the greatest average solubility (28.3%) and was significantly higher 
compared to sample A9 and A12-A15 (p<0.05). Its solubility was approximately 34% of the 
SeMet. These results could be explained by the higher concentration of selenate added to the 
growth medium, the shorter cultivation time compared to the other samples, and having no 
sulfite in the medium. 
Algae can successfully absorb larger amounts of inorganic Se and can metabolize it to 
organic forms of Se. This includes generation of selenoproteins and incorporation into other 
proteins for storage and later use37,38. Some studies report that methylated forms of Se can be 
generated24,39. What is currently not clear though, is exactly what type and how much organic Se 
is formed following absorption of inorganic Se, creating challenges for assessing the BA115. The 
composition of algae may play a major role in how Se is metabolized and utilized. Fiber and 
sulfur content, for example, could inhibit Se absorption, particularly organic Se113. Lastly, pH of 
the simulated digestion could affect the results for all of the treatments. The pH of 6 that was 
used in our in vitro digestion protocol was reflective of duodenal pH, which is commonly used 
for iron40. However, Se is absorbed to the greatest extent in the jejunum17,41. Perhaps using a 
slightly higher pH to mimic further down the small intestine could increase absorption of all the 
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treatments, but a different cell line has to be used for this. Overall, our results for solubility with 
the SeMet, Yeast, and inorganic Se-salts are consistent with current literature2,14,32. 
Bioavailability 
To assess the BA of the Se-rich algae we utilized GPx activity in the cell extracts after Se 
was taken up by the cell. Figure 3.1 shows the Se-deficient cells had approximately a 70% 
reduction in GPx activity and which was significantly lower compared to the Se sufficient cells 
(P<0.05). These results were slightly different from the methods used in a published study (Zeng 
et al., 2008) that showed an 80% reduction in GPx activity in their Se-deficient model28. We 
assumed that not all forms of Se, although having similar BAC, would induce GPx to the same 
extent. Concentration and chemical form are key factors regarding the ability for Se to induce 
GPx activity. Using the same concentration of 100 nmol/L of Se in each cell treatment allowed 
for easy comparison between each sample result. Different concentrations might have a different 
effect based on the relationship to GPx, therefore, using a different concentration that used in this 
study may produce different results.  
Figure 3A compares the GPx activity of the algae samples cultivated in selenite under 
different conditions as described in the methods to SeMet, Na2SeO3, and Yeast. The Yeast and 
Na2SeO3 had the highest GPx activity of 771 mU/mg cell protein and 725 mU/mg cell protein, 
respectively, and were not significantly different (p>0.05). They were significantly different 
(p<0.05) compared to SeMet, which had a lower GPx activity. SeMet had an average GPx 
activity of 574.1 mU/mg cell protein. The GPx activity of Na2SeO3 was 126% of the SeMet and 
the Yeast GPx activity was 134% of SeMet. All of the algae samples had a significantly lower 
(p<0.05) GPx activity compared to SeMet, Na2SeO3, and Yeast and we couldn’t identify any of 
the algae samples as superior. Sample A1 did appear to have a better overall GPx activity but it
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was only significantly different (p<0.05) in GPx activity to sample A5, which was cultivated in a 
higher concentration of selenite and harvested at a later time. The growth conditions for sample 
A5 included 50 ppm selenite in media, 0 ppm sulfite, and harvested at week 3 of growth with 
0.25% Se in dry mass.  
Figure 3B compares the GPx activity of the algae samples grown in selenate to SeMet, 
Na2SeO4, and Yeast. The GPx activity of Na2SeO4 was 214% of the SeMet GPx activity. All 
selenate algae samples had a significantly lower (p<0.05) GPx activity compared to SeMet, 
Na2SeO4, and Yeast. Sample A6 growth conditions consisted of 200 ppm selenate in media, 0 
ppm sulfite, and harvested at week 5 of growth with 0.58% Se in dry mass. It had the highest 
GPx activity (354.4 mU/mg cell protein) though and was significantly different (p<0.05) 
compared to the other algae samples, except for sample A7 which had the same growth 
conditions but was harvested at week 3 of growth. In general, the algae grown in the higher 
concentration of selenate (200 ppm) with no sulfite appeared to have a better BAC than all other 
algae samples. 
 It is clear that Se solubility may not be the best predictor of the Se BA. The inorganic 
selenite and selenate showed higher GPx activity compared to SeMet which could be explained 
by the direct reduction to H2Se before incorporation into selenoproteins, compared to the longer 
pathway that organic Se uses12,42,43. Organic Se is not directly transformed to H2Se and may go 
through other routes such as incorporation into body proteins in place of methionine44,45. No 
matter the concentration or the form of Se, BA from Se-rich algal samples was very low 
compared to organic and inorganic Se. Knowing how algae metabolizes the inorganic Se it 
absorbs is important because it is clear that there is a difference in BA between organic and 
inorganic Se. As with solubility, considering factors such as algal composition could further the 
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understanding of its BA Algal biomass could simply be more difficult to digest and finding other 
ways to improve the digestion could improve the BAC, and perhaps the BA. Because the algae 
Chlorella sp. provides a higher amount of protein including essential amino acids, 
monounsaturated and polyunsaturated fatty acids, fiber, vitamins, and minerals, it has much to 
offer in terms of nutritional benefits26,28,29. It also has a positive impact on the environment when 
considering how well it can remove certain nutrients from water sources that may have a 
negative impact if not removed34. Because algae can be cultivated so efficiently and effectively, 
it is very promising to use for biotechnological purposes, such as creating a natural supplement 
for humans or animals.   
This study helps represents the complexity that exists among Se absorption and metabolism. 
Se-rich algae is emerging in research for its potential to remove Se from wastewaters and areas 
in the environment that have high Se concentration. Although this study did not show the 
bioaccessiblity and bioavailability of Se-rich algae near as great as traditional forms of Se used 
in supplementation, it offers insight for future research with algae. 
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Table 1. Description of Se-rich algal samples grown in either a selenite or selenate-rich 
medium 
 Selenitea  Selenatea 
selenite 
(ppm) 
sulfite 
(ppm) 
wk of 
harvest 
Se in 
dry 
mass 
(%) 
abbrev. selenate 
(ppm) 
sulfite 
(ppm) 
wk of 
harvest 
Se in 
dry 
mass 
(%) 
abbrev. 
30 0 1 0.51 A1 200 0 5 0.58 A6 
30 0 3 1.00 A2 200 0 3 0.50 A7 
30 0 2 0.56 A3 200 0 2 0.31 A8 
200 200 3 0.16 A4 100 0 3 0.30 A9 
50 0 3 0.25 A5 50 0 5 0.25 A10 
  100 0 5 0.40 A11 
  100 0 4 0.23 A12 
  50 0 2 0.29 A13 
  50 0 1 0.13 A14 
  50 0 3 0.24 A15 
a All samples displayed were grown in the Revolving Algal Biofilm system with bold basal 
medium 
 
 
Figure 3.1 
 
Figure 3.1 A Se deficient cell model. Caco-2 cells grown in DMEM with 10% FBS compared to 
Caco-2 cells grown in serum free DMEM using a gradual serum reduction method. Cells grown 
in serum free DMEM have approximately 70% reduction in GPx activity compared to cells 
grown in DMEM with 10% FBS. * Data represents mean ± SD of duplicates and considered 
significantly different at P<0.05 by Student t-test. 
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Figure 3.2 
 
Figure 3.2 (A) Solubility (%) of algal samples grown in selenite medium compared to solubility 
of SeMet, Na2SeO3, and Yeast supplement. (B) Solubility of algal samples grown in selenate 
medium compared to solubility of SeMet, Na2SeO4, and Yeast supplement. Data represents mean 
± SD of duplicates and those not sharing the same letter are considered significantly different. 
 
Figure 3.3 
 
Figure 3.3 (A) GPx activity of algal samples grown in selenite medium compared to GPx 
activity of SeMet, Na2SeO3, and Yeast supplement. (B) GPx activity of algal samples grown in 
selenate medium compared to GPx activity of SeMet, Na2SeO4, and Yeast supplement. Data 
represents mean ± SD and those not sharing the same letter are considered significantly different 
(P<0.05) (ANOVA with Tukey multiple comparison); n=3 for SeMet, Na2SeO3, and A1; n=4 for 
all other samples. GPx activity shown as mU/mg cell protein or umol/min/mL/mg protein. 
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CHAPTER 4: GENERAL CONCLUSIONS 
This study investigated the BAC and BA of Se from algae grown in media containing 
varying concentrations of Se as selenite or selenate. The main focus was to find the best growth 
conditions for algae to have an optimal Se BA, as there is currently no known data about Se BA 
from algae. The soluble concentration of Se following in vitro digestion allowed for determining 
the BAC of each sample and the induction of GPx1 activity allowed for evaluation of BA of each 
sample. The results of the study found that the Se-rich algae had lower BAC and BA when 
compared to organic and inorganic forms traditionally used in supplementation (SeMet, Yeast, 
Na2SeO3, and Na2SeO4). The SeMet, Yeast, Na2SeO3, and Na2SeO4 were comparable in BAC 
while all the Se-rich algae samples were significantly lower (P<0.05). It was found that Na2SeO4 
had the highest BA compared to SeMet, Na2SeO3, and the Yeast, and the Se-rich algae was 
significantly lower than all of them (P<0.05).  
We acknowledge that there were several limitations to the study. Based on the 
methodology used for in vitro digestion mimicking the duodenal environment, using a 
methodology that mimics the latter part of the small intestine may produce different results. This 
could include increasing the pH from 6 to 7 and changing the particle size of the algal samples. 
Further, a different cell line could be utilized to better represent the latter part of the small 
intestine. These findings show that the algal samples are not yet promising for having Se BA 
comparable to current forms of Se used in supplementation. However, certain algae species such 
as Chlorella sp. have much to offer still in terms of health benefits because of its rich protein, 
fatty acid, vitamin, and mineral content. Developing a Se-rich algae supplement could provide a 
natural product for supplementation that not only offers a variety of important nutrients, but also 
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benefits the environment by acting as a natural source to remove Se from areas of potential 
toxicity. Overall, this algae has much to offer because of its composition and ability to 
effectively remove Se from the environment. Future studies can be performed to hopefully 
improve the algal digestion and perhaps, BA.   
   
  
